Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170038/S025

CentriMag Circulatory Support System

Abbott · Decision date Dec 1, 2025

FDA DECISIONP170038/S025

What did the FDA approve?

FDA records P170038/S025 as a supplement to PMA P170038, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Dec 1, 2025.

FDA approval order statement

approval of changes to the CentriMag Circulatory Support System Clinical Reference Manual to include information on the CentriMag FTW Post-Approval Study
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Dec 1, 2025
FDA change category
Labeling Change - PAS

FDA source record

Regulatory record facts

Identifier
P170038/S025
Regulatory pathway
PMA supplement
Applicant
Abbott
Product code
DSQ
Decision code
APPR
Decision date
Dec 1, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Abbott
Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170038 · Original PMA

    CentriMag Circulatory Support System

  2. P170038/S025 received

    Application receipt date recorded by FDA.

  3. P170038/S026 · Related supplement

    CentriMag Circulatory Support System

  4. P170038/S023 · Related supplement

    CentriMag Circulatory Support System

  5. P170038/S025 · FDA decision

    Normal 180 Day Track No User Fee

  6. P170038/S027 · Related supplement

    CentriMag Circulatory Support System

  7. P170038/S028 · Related supplement

    CentriMag Circulatory Support System

  8. P170038/S029 · Related supplement

    CentriMag Circulatory Support System

  9. P170038/S030 · Related supplement

    CentriMag Circulatory Support System

  10. P170038/S031 · Related supplement

    CentriMag Circulatory Support System

  11. P170038/S032 · Related supplement

    CentriMag Circulatory Support System

  12. P170038/S033 · Related supplement

    CentriMag Circulatory Support System

  13. P170038/S034 · Related supplement

    CentriMag Circulatory Support System

Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170038

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA approvalDec 6, 2019FDA
AbbottPMA supplementAug 21, 2025FDA
AbbottPMA supplementSep 29, 2025FDA
AbbottPMA supplementFeb 3, 2026FDA
AbbottPMA supplementFeb 18, 2026FDA
AbbottPMA supplementApr 17, 2026FDA
AbbottPMA supplementMay 4, 2026FDA
AbbottPMA supplementMay 5, 2026FDA
AbbottPMA supplementSep 2, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
AbbottPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records